Claim Construction Turns On Patentee Disclaimer – Mondaq News Alerts (registration)
|
Claim Construction Turns On Patentee Disclaimer
Mondaq News Alerts (registration) Declining to hold that one epitope can count as two, the U.S. Court of Appeals for the Federal Circuit upheld a lower court’s narrow construction of the term “anti-CD20 antibody,” finding that patentees disclaimed the use of anti-CD20 antibodies … |
